Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

  • Dansk
  • NL
  • EN
  • FI
  • FR
  • DE
  • EL
  • IT
  • NO
  • PL
  • PT
  • RO
  • SL
  • ES
  • SV

Secret safety studies undermine EFSA's transparency claims

Europe's public food safety watchdog, the European Food Safety Authority (EFSA) is still not up to its responsibilities when it comes to transparency, claims a coalition of civil society groups in an open letter. The signatories denounce the secrecy around safety studies, ahead of EFSA’s conference on transparency that will take place tomorrow (3 October 2013) in Parma as part of its transparency initiative.

Currently, EFSA does very little original research. It elaborates its opinions on the safety of all food and food-related products (such as additives, pesticides or GMOs) using dossiers of studies and analyses performed or sponsored by the very same companies that are applying for market authorization of these products in the EU. But these dossiers and the raw data of the tests summarized in them are routinely kept secret under commercial confidentiality agreements with regulators.

“Having industry perform and report the tests on which authorizations are based casts doubt on the validity of the entire authorization process,” said Nina Holland, a researcher and campaigner at Corporate Europe Observatory (CEO). “The fact that the details of the tests are kept secret only adds to the lack of public confidence in EFSA's assessments. The minimum solution to this situation is full and pro-active transparency of these dossiers from the moment they are submitted to EFSA, pending a more adequate risk assessment system.”

For now, public access to these studies has been hard-won and partial. In some cases, disclosure could only be obtained by legal action1. As an example, this year, in the wake of the controversy caused by a long-term study on a type of maize produced by Monsanto (glyphosate-tolerant NK603 maize)2, EFSA published parts of Monsanto’s dossier, which triggered legal threats by the company. Today, the risk assessment studies on glyphosate, the most used pesticide in the world, remain secret, which is also the case for industry data on all pesticides.

Martin Pigeon, a researcher and campaigner with CEO, said: “Transparency isn’t only needed to improve public confidence in EFSA’s work but also in order to ensure EFSA’s assessments are based on sound science. A fundamental principle of science is replicability: the methodology and results of the industry tests need to be made public so that other scientists can replicate the test and see if they get the same result. Yet apparently we are supposed to take industry’s results – which we can’t even see – on faith. This is unreliable and unacceptable.”

Photo: IAEA Imagebank (CC 2.0 by-nc-nd)

  • 1. Séralini, G. E., et al. (2007). New analysis of a rat feeding study with a genetically modified maize reveals signs of hepatorenal toxicity. Archives of Environmental Contamination and Toxicology 52(4): 596–602
  • 2. Séralini, G. E., et al. (2012). Long term toxicity of a Roundup herbicide and a Roundup-tolerant genetically modified maize. Food and Chemical Toxicology 50(11): 4221-4231
Related issues: 
 

More than 80 per cent of the national experts involved in the EU's official assessment of glyphosate refused to have their names disclosed to the public.

Monsanto and the pesticide industry breathed a collective sigh of relief on 12 November 2015. The findings of an investigation into the toxicity of glyphosate by the European Food Safety Authority (EFSA) and EU Member States were in stark contradiction to the March 2015 conclusion by the International Agency for Research against Cancer (IARC), a body of the World Health Organization (WHO), that this agricultural herbicide was probably causing cancer to humans. If validated, this conclusion could cause a partial ban of glyphosate in the EU. [UPDATED on 30 11 2015 16.30 CET]

Open letter to Commissioner Andriukaitis on glyphosate

Heard by the European Parliament's Committee on the Environment, Public Health and Food Safety, Bernhard Url, EFSA's director, said that the EU had "enough scientific capability around [...] without a chief scientific adviser".

Commission refuses to act on the recommendations of the European Ombudsman regarding tobacco industry lobbying.

CEO turns the spotlight on another of the interest groups operating within the European Parliament.

At least one developer of new GM crops – Canadian-based Cibus – has attempted to bypass the European policy process by presenting policy makers with a fait accompli: decisions by individual Member States on the regulatory status of new techniques, as well as prematurely-launched trials of new GM crops.

The biotech industry is staging an audacious bid to have a whole new generation of genetic engineering techniques excluded from European regulations. The pending decision of the European Commission on the regulation of these so-called 'new GMOs' represents a climax point in the ongoing below-the-radar attack by industry on GM laws.

The corporate lobby tour

Stop the Crop

Alternative Trade Mandate